Securities Trading Policy

Summary of guidelines on buying and selling Avexa securities

1. General Rule

Directors and employees of Avexa should not buy or sell securities in Avexa, when Avexa is in possession of price sensitive information that is not generally available to the market.

2. Notification and approval requirements

Any director or employee or Avexa proposing to buy or sell Avexa securities must advise the Chairman (in the case of directors) or the Chief Executive Officer (in the case of employees) in writing of their intention to do so before buying or selling the securities. This notification obligation operates at all times.

Directors and employees must not buy or sell Avexa securities until approval has been given by the Board, Chairman or Chief Executive Officer. The Board, Chairman or Chief Executive Officer should not reasonably withhold approval and if a response is not received within 48 hours of the advice, approval will deemed to have been given.

3. Australian Stock Exchange Limited notification by directors

The Australian Stock Exchange listing rules oblige any director dealing in Avexa securities to notify Avexa through Avexa™s Company Secretary within 3 days after any dealing providing full details of the dealing in accordance with the ASX prescribed Appendix 3Y form.

Financial reporting

The Avexa Audit Committee currently comprises the full Board of Directors except for the Chief Executive Officer. However, upon the establishment of a Board comprised of a majority of independent non-executive Directors it is intended to constitute the Committee with a majority of independent directors in accordance with the ASX Guidelines on independence.

Continuous disclosure

As a public listed company, Avexa is required to comply with the Australian Stock Exchange Ltd (ASX) Listing Rules continuous disclosure obligations.